NovoCure Limited
NVCR
Cena:
$ 18.26
+0.30 (1.67%)
Valuace
70
Růst
15
Zdraví
69
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| FMR LLC | 17.1 mil | 15.31% | 0.00% | 0.01% | 2015-12-31 |
| BLACKROCK FUNDING, INC. /DE | 13.0 mil | 12.03% | 0.00% | 0.01% | 2024-09-30 |
| BLACKROCK, INC. | 13.2 mil | 11.84% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK INC. | 12.1 mil | 11.31% | 0.00% | 0.00% | 2016-03-31 |
| VANGUARD GROUP INC | 11.0 mil | 9.79% | 0.00% | 0.00% | 2015-12-31 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 10.5 mil | 9.41% | 0.56% | 4.63% | 2023-03-31 |
| CAPITAL INTERNATIONAL INVESTORS | 8.9 mil | 8.11% | -0.02% | 0.03% | 2018-12-31 |
| 4.7 mil | 4.20% | 0.00% | 0.00% | 2026-03-31 | |
| MORGAN STANLEY | 4.5 mil | 4.07% | 0.00% | 0.00% | 2015-12-31 |
| WELLS FARGO & COMPANY/MN | 3.0 mil | 2.65% | 0.01% | 0.01% | 2015-12-31 |
| STATE STREET CORP | 2.6 mil | 2.30% | 0.00% | 0.00% | 2015-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5 mil | 2.25% | 0.00% | 0.00% | 2015-12-31 |
| QUANTINNO CAPITAL MANAGEMENT LP | 2.5 mil | 2.23% | -0.01% | 0.05% | 2023-12-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 2.3 mil | 2.03% | 0.01% | 0.06% | 2023-03-31 |
| CAPITAL WORLD INVESTORS | 2.0 mil | 1.79% | -0.01% | 0.00% | 2018-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.6 mil | 1.39% | 0.00% | 0.03% | 2023-12-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.4 mil | 1.22% | 0.01% | 0.02% | 2025-06-30 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.3 mil | 1.19% | 0.00% | 0.06% | 2025-06-30 |
| PALO ALTO INVESTORS LP | 1.3 mil | 1.15% | -0.20% | 2.13% | 2023-03-31 |
| SG AMERICAS SECURITIES, LLC | 1.2 mil | 1.12% | 0.01% | 0.01% | 2016-09-30 |
| BAILLIE GIFFORD & CO | 1.1 mil | 0.96% | 0.00% | 0.01% | 2017-12-31 |
| AMERICAN CENTURY COMPANIES INC | 1.0 mil | 0.93% | 0.00% | 0.01% | 2025-03-31 |
| MARSHALL WACE, LLP | 1.0 mil | 0.93% | -0.01% | 0.01% | 2023-03-31 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.0 mil | 0.92% | 0.00% | 0.01% | 2025-09-30 |
| NORGES BANK | 974.05 tis | 0.91% | 0.00% | 0.00% | 2023-12-31 |
| NUVEEN, LLC | 982.35 tis | 0.88% | 0.00% | 0.00% | 2025-03-31 |
| C WORLDWIDE GROUP HOLDING A/S | 971.78 tis | 0.87% | 0.01% | 0.23% | 2017-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 960.06 tis | 0.86% | 0.00% | 0.00% | 2018-09-30 |
| JPMORGAN CHASE & CO | 930.17 tis | 0.83% | 0.00% | 0.00% | 2017-12-31 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 927.38 tis | 0.83% | 0.01% | 0.01% | 2024-06-30 |
| CREDIT SUISSE AG/ | 847.52 tis | 0.80% | 0.00% | 0.01% | 2016-06-30 |
| NORTHERN TRUST CORP | 883.58 tis | 0.79% | 0.00% | 0.00% | 2015-12-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 837.49 tis | 0.75% | 0.00% | 0.00% | 2015-12-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 825.12 tis | 0.74% | 0.04% | 0.27% | 2025-03-31 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 784.81 tis | 0.70% | 0.00% | 0.06% | 2024-06-30 |
| BANQUE PICTET & CIE SA | 750.00 tis | 0.70% | 0.09% | 0.09% | 2023-12-31 |
| GOLDMAN SACHS GROUP INC | 745.44 tis | 0.67% | 0.00% | 0.00% | 2015-12-31 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 726.40 tis | 0.65% | -0.01% | 0.01% | 2025-12-31 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 716.54 tis | 0.64% | 0.00% | 0.02% | 2023-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 712.77 tis | 0.64% | 0.00% | 0.00% | 2026-03-31 |
| BNP PARIBAS ARBITRAGE, SNC | 708.29 tis | 0.64% | 0.00% | 0.00% | 2015-12-31 |
| CITIGROUP INC | 705.65 tis | 0.63% | 0.01% | 0.01% | 2015-12-31 |
| CITADEL ADVISORS LLC | 675.83 tis | 0.60% | 0.00% | 0.00% | 2016-12-31 |
| D. E. SHAW & CO., INC. | 647.06 tis | 0.58% | 0.00% | 0.00% | 2022-06-30 |
| MILLENNIUM MANAGEMENT LLC | 646.67 tis | 0.58% | 0.00% | 0.00% | 2015-12-31 |
| ALGERT GLOBAL LLC | 625.80 tis | 0.56% | -0.07% | 0.10% | 2024-03-31 |
| COATUE MANAGEMENT LLC | 608.67 tis | 0.55% | -0.01% | 0.05% | 2023-06-30 |
| GRANITE INVESTMENT PARTNERS, LLC | 604.05 tis | 0.54% | -0.07% | 0.52% | 2024-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 565.10 tis | 0.51% | 0.00% | 0.00% | 2015-12-31 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 495.31 tis | 0.47% | 0.50% | 0.73% | 2023-12-31 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 509.64 tis | 0.46% | 0.00% | 0.01% | 2025-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 482.03 tis | 0.44% | 0.00% | 0.00% | 2018-06-30 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 481.35 tis | 0.43% | -0.06% | 0.06% | 2017-06-30 |
| EMERALD ADVISERS, LLC | 461.37 tis | 0.41% | -0.13% | 0.30% | 2024-12-31 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 452.37 tis | 0.41% | 0.78% | 0.78% | 2026-03-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 415.11 tis | 0.38% | 0.03% | 0.04% | 2023-06-30 |
| SIO CAPITAL MANAGEMENT, LLC | 413.83 tis | 0.37% | 1.35% | 1.35% | 2025-09-30 |
| WOODLINE PARTNERS LP | 391.46 tis | 0.37% | 0.06% | 0.06% | 2023-12-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 407.20 tis | 0.36% | -0.01% | 0.02% | 2023-03-31 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 393.33 tis | 0.35% | -0.03% | 0.02% | 2018-09-30 |
| SCHONFELD STRATEGIC ADVISORS LLC | 363.78 tis | 0.34% | 0.03% | 0.04% | 2023-09-30 |
| AXA INVESTMENT MANAGERS S.A. | 371.77 tis | 0.33% | 0.01% | 0.01% | 2025-09-30 |
| AXA S.A. | 371.77 tis | 0.33% | 0.00% | 0.02% | 2025-03-31 |
| NUVEEN ASSET MANAGEMENT, LLC | 358.95 tis | 0.33% | 0.00% | 0.00% | 2018-03-31 |
| JUMP FINANCIAL, LLC | 368.38 tis | 0.33% | -0.04% | 0.05% | 2023-12-31 |
| INVUS FINANCIAL ADVISORS, LLC | 350.88 tis | 0.33% | 2.38% | 6.74% | 2019-12-31 |
| HRT FINANCIAL LP | 363.54 tis | 0.33% | 0.01% | 0.02% | 2025-06-30 |
| SIREN, L.L.C. | 350.88 tis | 0.32% | 0.27% | 0.27% | 2024-09-30 |
| PANAGORA ASSET MANAGEMENT INC | 349.81 tis | 0.32% | -0.01% | 0.03% | 2024-03-31 |
| TWO SIGMA INVESTMENTS, LP | 352.46 tis | 0.32% | 0.00% | 0.01% | 2017-12-31 |
| SQUAREPOINT OPS LLC | 331.18 tis | 0.31% | 0.01% | 0.01% | 2017-12-31 |
| BANK OF AMERICA CORP /DE/ | 342.95 tis | 0.31% | 0.00% | 0.00% | 2015-12-31 |
| LEGAL & GENERAL GROUP PLC | 330.94 tis | 0.30% | 0.00% | 0.00% | 2016-12-31 |
| JANE STREET GROUP, LLC | 319.81 tis | 0.29% | 0.00% | 0.00% | 2018-12-31 |
| IEQ CAPITAL, LLC | 314.73 tis | 0.28% | 0.00% | 0.02% | 2025-06-30 |
| DEUTSCHE BANK AG\ | 314.08 tis | 0.28% | 0.00% | 0.00% | 2015-12-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 313.22 tis | 0.28% | 0.00% | 0.00% | 2023-12-31 |
| MAN GROUP PLC | 300.17 tis | 0.28% | -0.01% | 0.01% | 2018-03-31 |
| BARCLAYS PLC | 297.42 tis | 0.27% | 0.00% | 0.00% | 2015-12-31 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 286.97 tis | 0.27% | 2.03% | 7.41% | 2024-06-30 |
| FRANKLIN RESOURCES INC | 289.30 tis | 0.26% | 0.00% | 0.00% | 2020-09-30 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 289.36 tis | 0.26% | 0.05% | 0.06% | 2025-06-30 |
| BANK OF NEW YORK MELLON CORP | 281.47 tis | 0.25% | 0.00% | 0.00% | 2015-12-31 |
| AQR CAPITAL MANAGEMENT LLC | 274.93 tis | 0.25% | 0.00% | 0.00% | 2023-09-30 |
| ACADIAN ASSET MANAGEMENT LLC | 262.15 tis | 0.24% | 0.00% | 0.00% | 2023-09-30 |
| TD ASSET MANAGEMENT INC | 253.15 tis | 0.23% | 0.00% | 0.01% | 2018-12-31 |
| NORDWAND ADVISORS, LLC | 256.63 tis | 0.23% | -0.19% | 0.53% | 2022-12-31 |
| VESTAL POINT CAPITAL, LP | 250.00 tis | 0.22% | -0.15% | 0.08% | 2025-09-30 |
| UBS GROUP AG | 245.82 tis | 0.22% | 0.00% | 0.00% | 2015-12-31 |
| NATIONAL BANK OF CANADA /FI/ | 233.00 tis | 0.22% | 0.01% | 0.01% | 2021-12-31 |
| INVENOMIC CAPITAL MANAGEMENT LP | 218.99 tis | 0.21% | -0.11% | 0.18% | 2023-12-31 |
| UBS ASSET MANAGEMENT AMERICAS INC | 228.27 tis | 0.20% | 0.00% | 0.00% | 2018-06-30 |
| TUDOR INVESTMENT CORP ET AL | 222.81 tis | 0.20% | 0.00% | 0.00% | 2019-03-31 |
| FEDERATED HERMES, INC. | 220.08 tis | 0.20% | -0.05% | 0.01% | 2023-09-30 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 219.58 tis | 0.20% | -0.17% | 0.24% | 2024-12-31 |
| ENGINEERS GATE MANAGER LP | 218.30 tis | 0.20% | -0.01% | 0.03% | 2023-03-31 |
| CI PRIVATE WEALTH, LLC | 216.51 tis | 0.19% | 0.00% | 0.00% | 2025-03-31 |
| EDGESTREAM PARTNERS, L.P. | 208.33 tis | 0.19% | 0.01% | 0.10% | 2024-09-30 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 202.03 tis | 0.19% | 0.00% | 0.00% | 2022-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 200.00 tis | 0.18% | 0.01% | 0.01% | 2024-12-31 |
| CAPTION MANAGEMENT, LLC | 196.20 tis | 0.18% | 0.05% | 0.05% | 2024-03-31 |
| TWINBEECH CAPITAL LP | 198.40 tis | 0.18% | 0.02% | 0.06% | 2023-03-31 |
| GROUP ONE TRADING, L.P. | 195.44 tis | 0.18% | 0.01% | 0.01% | 2023-03-31 |
| SWISS NATIONAL BANK | 199.10 tis | 0.18% | 0.00% | 0.00% | 2016-06-30 |
| PDT PARTNERS, LLC | 188.42 tis | 0.18% | 0.03% | 0.31% | 2023-12-31 |
| INVESCO LTD. | 189.47 tis | 0.18% | 0.00% | 0.00% | 2017-09-30 |
| TREXQUANT INVESTMENT LP | 185.94 tis | 0.17% | -0.04% | 0.05% | 2022-12-31 |
| TWO SIGMA ADVISERS, LP | 189.50 tis | 0.17% | -0.01% | 0.01% | 2017-12-31 |
| TAYLOR FRIGON CAPITAL MANAGEMENT LLC | 160.05 tis | 0.15% | 0.16% | 1.25% | 2018-12-31 |
| RHUMBLINE ADVISERS | 150.12 tis | 0.14% | 0.00% | 0.00% | 2016-06-30 |
| CAPITAL FUND MANAGEMENT S.A. | 100.69 tis | 0.09% | 0.00% | 0.01% | 2023-03-31 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 99.61 tis | 0.09% | 0.00% | 0.00% | 2015-12-31 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 84.50 tis | 0.08% | 0.01% | 0.01% | 2024-06-30 |
| SPIDERROCK ADVISORS, LLC | 80.69 tis | 0.08% | 0.00% | 0.03% | 2024-03-31 |
| HSBC HOLDINGS PLC | 73.82 tis | 0.07% | 0.00% | 0.00% | 2022-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| VERNON W ANTHONY | director | M-Exempt | 21500 | 11.39 | 28.4 2026 | 0 |
| VERNON W ANTHONY | director | M-Exempt | 21500 | 11.39 | 28.4 2026 | 200602 |
| DOYLE WILLIAM F | director, officer: Executive Chairman | A-Award | 200000 | 0.00 | 5.3 2026 | 200000 |
| DOYLE WILLIAM F | director, officer: Executive Chairman | A-Award | 258445 | 13.30 | 5.3 2026 | 258445 |
| DOYLE WILLIAM F | director, officer: Executive Chairman | A-Award | 30072 | 13.30 | 5.3 2026 | 288517 |
| DOYLE WILLIAM F | director, officer: Executive Chairman | S-Sale | 21330 | 13.43 | 5.3 2026 | 328397 |
| DOYLE WILLIAM F | director, officer: Executive Chairman | S-Sale | 50557 | 12.79 | 5.3 2026 | 349727 |
| DOYLE WILLIAM F | director, officer: Executive Chairman | A-Award | 200284 | 0.00 | 5.3 2026 | 400284 |
| Puri Michal Nath | officer: Chief Human Resources Officer | A-Award | 58672 | 13.30 | 5.3 2026 | 58672 |
| Puri Michal Nath | officer: Chief Human Resources Officer | S-Sale | 1100 | 13.31 | 5.3 2026 | 201322 |
| Puri Michal Nath | officer: Chief Human Resources Officer | A-Award | 40100 | 0.00 | 5.3 2026 | 202422 |
| Paravasthu Mukund | officer: Chief Operating Officer | A-Award | 7518 | 13.30 | 5.3 2026 | 7518 |
| Paravasthu Mukund | officer: Chief Operating Officer | A-Award | 58488 | 13.30 | 5.3 2026 | 66006 |
| Paravasthu Mukund | officer: Chief Operating Officer | S-Sale | 43246 | 13.77 | 5.3 2026 | 72832 |
| Paravasthu Mukund | officer: Chief Operating Officer | S-Sale | 5377 | 13.31 | 5.3 2026 | 116078 |
| Paravasthu Mukund | officer: Chief Operating Officer | A-Award | 45112 | 0.00 | 5.3 2026 | 121455 |
| Leonard Frank X | officer: Chief Executive Officer | A-Award | 216388 | 13.30 | 5.3 2026 | 216388 |
| Leonard Frank X | officer: Chief Executive Officer | S-Sale | 5607 | 13.31 | 5.3 2026 | 493793 |
| Leonard Frank X | officer: Chief Executive Officer | A-Award | 150000 | 0.00 | 5.3 2026 | 499400 |
| Brackmann Christoph | officer: Chief Financial Officer | A-Award | 80674 | 13.30 | 5.3 2026 | 80674 |
| Brackmann Christoph | officer: Chief Financial Officer | S-Sale | 6412 | 13.31 | 5.3 2026 | 182842 |
| Brackmann Christoph | officer: Chief Financial Officer | A-Award | 55137 | 0.00 | 5.3 2026 | 189254 |
| Weinberg Uri | officer: Chf Medical and Innovation Ofr | A-Award | 73340 | 13.30 | 5.3 2026 | 73340 |
| Weinberg Uri | officer: Chf Medical and Innovation Ofr | S-Sale | 6412 | 13.31 | 5.3 2026 | 267190 |
| Weinberg Uri | officer: Chf Medical and Innovation Ofr | A-Award | 50125 | 0.00 | 5.3 2026 | 273602 |
| Ben Arye Barak | officer: General Counsel | A-Award | 73340 | 13.30 | 5.3 2026 | 73340 |
| Ben Arye Barak | officer: General Counsel | A-Award | 50125 | 0.00 | 5.3 2026 | 242453 |
| Cordova Ashley | officer: Former Chief Executive Officer | F-InKind | 17638 | 13.30 | 5.3 2026 | 422570 |
| Leupin Nicolas | officer: Former Chief Medical Officer | S-Sale | 1100 | 13.31 | 5.3 2026 | 102979 |
| Ben Arye Barak | officer: General Counsel | A-Award | 17755 | 0.00 | 3.3 2026 | 192328 |
| Cordova Ashley | officer: Former Chief Executive Officer | F-InKind | 11541 | 13.75 | 3.3 2026 | 426028 |
| Cordova Ashley | officer: Former Chief Executive Officer | F-InKind | 7228 | 13.67 | 3.3 2026 | 440208 |
| Cordova Ashley | officer: Former Chief Executive Officer | F-InKind | 2410 | 13.67 | 3.3 2026 | 447436 |
| Cordova Ashley | officer: Former Chief Executive Officer | A-Award | 23818 | 0.00 | 3.3 2026 | 449846 |
| Leonard Frank X | officer: Chief Executive Officer | S-Sale | 9734 | 13.66 | 3.3 2026 | 338011 |
| Leonard Frank X | officer: Chief Executive Officer | S-Sale | 7232 | 13.49 | 3.3 2026 | 349400 |
| Leonard Frank X | officer: Chief Executive Officer | A-Award | 18621 | 0.00 | 3.3 2026 | 356632 |
| Puri Michal Nath | officer: Chief Human Resources Officer | S-Sale | 1441 | 13.66 | 3.3 2026 | 162322 |
| Weinberg Uri | officer: Chf Medical and Innovation Ofr | S-Sale | 7461 | 13.84 | 3.3 2026 | 213757 |
| Weinberg Uri | officer: Chf Medical and Innovation Ofr | S-Sale | 3272 | 13.33 | 3.3 2026 | 223477 |
| Weinberg Uri | officer: Chf Medical and Innovation Ofr | A-Award | 12992 | 0.00 | 3.3 2026 | 226749 |
| Paravasthu Mukund | officer: Chief Operating Officer | F-InKind | 2133 | 14.35 | 12.1 2026 | 78306 |
| Ben Arye Barak | 0 | 0.00 | 8.1 2026 | 0 | ||
| Danziger Asaf | 0 | 0.00 | 8.1 2026 | 0 | ||
| Puri Michal Nath | 0 | 0.00 | 8.1 2026 | 0 | ||
| Puri Michal Nath | officer: Chief Human Resources Officer | F-InKind | 752 | 12.82 | 4.11 2025 | 163762 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | F-InKind | 966 | 12.81 | 4.11 2025 | 347745 |
| Paravasthu Mukund | officer: Chief Operating Officer | F-InKind | 2949 | 12.23 | 4.11 2025 | 80439 |
| Paravasthu Mukund | officer: Chief Operating Officer | F-InKind | 168 | 12.81 | 4.11 2025 | 83388 |
| Brackmann Christoph | officer: Chief Financial Officer | F-InKind | 7033 | 12.23 | 4.11 2025 | 134117 |
| Cordova Ashley | officer: Chief Executive Officer | P-Purchase | 81550 | 12.22 | 8.9 2025 | 437569 |
| Brackmann Christoph | officer: Chief Financial Officer | P-Purchase | 10000 | 11.63 | 30.7 2025 | 131150 |
| Brackmann Christoph | officer: Chief Financial Officer | P-Purchase | 5000 | 11.60 | 30.7 2025 | 136150 |
| Brackmann Christoph | officer: Chief Financial Officer | P-Purchase | 5000 | 11.50 | 30.7 2025 | 141150 |
| Ben Arye Barak | officer: General Counsel | A-Award | 769 | 15.13 | 1.7 2025 | 174465 |
| Cordova Ashley | officer: Chief Executive Officer | A-Award | 833 | 15.13 | 1.7 2025 | 356019 |
| Danziger Asaf | director | A-Award | 833 | 15.13 | 1.7 2025 | 416473 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | A-Award | 833 | 15.13 | 1.7 2025 | 348711 |
| Puri Michal Nath | officer: Chief Human Resources Officer | A-Award | 833 | 15.13 | 1.7 2025 | 164514 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | A-Award | 179426 | 0.00 | 6.6 2025 | 347878 |
| VERNON W ANTHONY | director | A-Award | 16697 | 16.72 | 6.6 2025 | 16697 |
| VERNON W ANTHONY | director | A-Award | 11215 | 0.00 | 6.6 2025 | 179102 |
| Hung David | director | A-Award | 16697 | 16.72 | 6.6 2025 | 16697 |
| Hung David | director | A-Award | 11215 | 0.00 | 6.6 2025 | 23410 |
| Scannell Timothy J | director | A-Award | 16697 | 16.72 | 6.6 2025 | 16697 |
| Scannell Timothy J | director | A-Award | 11215 | 0.00 | 6.6 2025 | 17233 |
| Ocean Allyson J | director | A-Award | 11215 | 0.00 | 6.6 2025 | 14269 |
| Ocean Allyson J | director | A-Award | 16697 | 16.72 | 6.6 2025 | 16697 |
| HILLEMAN JERYL L | director | A-Award | 16697 | 16.72 | 6.6 2025 | 16697 |
| HILLEMAN JERYL L | director | A-Award | 11215 | 0.00 | 6.6 2025 | 16806 |
| Madden Martin J. | director | A-Award | 33393 | 16.72 | 6.6 2025 | 33393 |
| Stafford Kristin | director | A-Award | 11215 | 0.00 | 6.6 2025 | 14269 |
| Stafford Kristin | director | A-Award | 16697 | 16.72 | 6.6 2025 | 16697 |
| LEUNG GABRIEL | director | A-Award | 16697 | 16.72 | 6.6 2025 | 16697 |
| LEUNG GABRIEL | director | A-Award | 11215 | 0.00 | 6.6 2025 | 92444 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | S-Sale | 1879 | 19.01 | 4.6 2025 | 168452 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | S-Sale | 6600 | 17.99 | 4.6 2025 | 170331 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | S-Sale | 21717 | 17.22 | 4.6 2025 | 176931 |
| Hung David | director | S-Sale | 999 | 17.30 | 4.6 2025 | 12195 |
| VERNON W ANTHONY | director | S-Sale | 999 | 17.35 | 4.6 2025 | 167887 |
| Ocean Allyson J | director | S-Sale | 999 | 17.29 | 4.6 2025 | 3054 |
| HILLEMAN JERYL L | director | S-Sale | 999 | 17.26 | 4.6 2025 | 5591 |
| Scannell Timothy J | director | S-Sale | 999 | 17.32 | 4.6 2025 | 6018 |
| Madden Martin J. | director | S-Sale | 999 | 17.19 | 4.6 2025 | 18674 |
| LEUNG GABRIEL | director | S-Sale | 999 | 17.31 | 4.6 2025 | 81229 |
| Stafford Kristin | director | S-Sale | 999 | 17.28 | 4.6 2025 | 3054 |
| Paravasthu Mukund | officer: Chief Operating Officer | S-Sale | 592 | 17.91 | 5.5 2025 | 83556 |
| Paravasthu Mukund | officer: Chief Operating Officer | A-Award | 54975 | 18.19 | 6.3 2025 | 84148 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | A-Award | 81499 | 18.19 | 6.3 2025 | 81499 |
| Leonard Frank X | officer: EVP, Pres., Novocure Oncology | A-Award | 54975 | 18.19 | 6.3 2025 | 198648 |
| Weinberg Uri | officer: Chief Innovation Officer | A-Award | 81499 | 18.19 | 6.3 2025 | 81499 |
| Weinberg Uri | officer: Chief Innovation Officer | A-Award | 54975 | 18.19 | 6.3 2025 | 221218 |
| Puri Michal Nath | officer: Chief Human Resources Officer | A-Award | 81499 | 18.19 | 6.3 2025 | 81499 |
| Puri Michal Nath | officer: Chief Human Resources Officer | A-Award | 54975 | 18.19 | 6.3 2025 | 163681 |
| Ben Arye Barak | officer: General Counsel | A-Award | 81499 | 18.19 | 6.3 2025 | 81499 |
| Ben Arye Barak | officer: General Counsel | A-Award | 54975 | 18.19 | 6.3 2025 | 173696 |
| Leupin Nicolas | officer: Chief Medical Officer | A-Award | 81499 | 18.19 | 6.3 2025 | 81499 |
| Leupin Nicolas | officer: Chief Medical Officer | A-Award | 54975 | 18.19 | 6.3 2025 | 105108 |
| Brackmann Christoph | officer: Chief Financial Officer | A-Award | 81499 | 18.19 | 6.3 2025 | 81499 |
| Brackmann Christoph | officer: Chief Financial Officer | A-Award | 54975 | 18.19 | 6.3 2025 | 121150 |
